{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:22:16Z","timestamp":1791922936919,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T00:00:00Z","timestamp":1546646400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81501955"],"award-info":[{"award-number":["81501955"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12944-018-0933-z","type":"journal-article","created":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T11:39:32Z","timestamp":1546688372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":120,"title":["Concurrent exercise improves insulin resistance and nonalcoholic fatty liver disease by upregulating PPAR-\u03b3 and genes involved in the beta-oxidation of fatty acids in ApoE-KO mice fed a high-fat diet"],"prefix":"10.1186","volume":"18","author":[{"given":"Fan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8766-6005","authenticated-orcid":false,"given":"Ying","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,5]]},"reference":[{"issue":"3","key":"933_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3803\/EnM.2018.33.3.387","volume":"33","author":"D Choi","year":"2018","unstructured":"Choi D, Jung C, Mok J, et al. Effect of Dapagliflozin on alanine aminotransferase improvement in type 2 diabetes mellitus with non-alcoholic fatty liver disease. Endocrinol Metab. 2018;33(3):387\u201394.","journal-title":"Endocrinol Metab"},{"issue":"41","key":"933_CR2","doi-asserted-by":"publisher","first-page":"15019","DOI":"10.1038\/nrdp.2015.19","volume":"1","author":"RA Defronzo","year":"2015","unstructured":"Defronzo RA, Ferrannini E, Groop L, et al. Type 2 diabetes mellitus. Nat Rev Dis Primers. 2015;1(41):15019.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"933_CR3","doi-asserted-by":"publisher","first-page":"e5129","DOI":"10.1590\/1414-431X20165129","volume":"49","author":"J Yu","year":"2016","unstructured":"Yu J, Zheng J, Liu XF, et al. Exercise improved lipid metabolism and insulin sensitivity in rats fed a high-fat diet by regulating glucose transporter 4 (GLUT4) and musclin expression. Braz J Med Biol Res. 2016;49(5):e5129.","journal-title":"Braz J Med Biol Res"},{"issue":"2","key":"933_CR4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/brv.12116","volume":"90","author":"CL Wu","year":"2015","unstructured":"Wu CL, Zhao SP, Yu BL. Intracellular role of exchangeable apolipoproteins in energy homeostasis, obesity and non-alcoholic fatty liver disease. Biol Rev Camb Philos Soc. 2015;90(2):367\u201376.","journal-title":"Biol Rev Camb Philos Soc"},{"issue":"3","key":"933_CR5","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","volume":"65","author":"G Targher","year":"2016","unstructured":"Targher G, Byrne CD, Lonardo A, et al. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol. 2016;65(3):589\u2013600.","journal-title":"J Hepatol"},{"issue":"6","key":"933_CR6","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/j.1440-1746.2004.03362.x","volume":"19","author":"SH Park","year":"2004","unstructured":"Park SH, Kim BI, Yun JW, et al. Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men. Eur J Gastroenterol Hepatol. 2004;19(6):694\u20138.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"933_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.dld.2014.09.020","volume":"47","author":"A Lonardo","year":"2015","unstructured":"Lonardo A, Ballestri S, Marchesini G, et al. Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome. Dig Liver Dis. 2015;47(3):181\u201390.","journal-title":"Dig Liver Dis"},{"issue":"2","key":"933_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/MED.0b013e3283444b09","volume":"18","author":"G Boden","year":"2011","unstructured":"Boden G. Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes. 2011;18(2):139.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"1","key":"933_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/jgh.12428","volume":"29","author":"Z Li","year":"2014","unstructured":"Li Z, Xue J, Chen P, Chen L, et al. Prevalence of nonalcoholic fatty liver disease in mainland of China: a meta-analysis of published studies. J Gastroenterol Hepatol. 2014;29(1):42\u201351.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"933_CR10","first-page":"e147985","volume":"11","author":"J Wei","year":"2016","unstructured":"Wei J, Lei GH, Fu L, et al. Association between dietary vitamin C intake and non-alcoholic fatty liver disease: a cross-sectional study among middle-aged and older adults. PLoS One. 2016;11(1):e147985.","journal-title":"PLoS One"},{"issue":"9","key":"933_CR11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrendo.2017.56","volume":"13","author":"M Rcr","year":"2017","unstructured":"Rcr M, Watt MJ. Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance. Nat Rev Endocrinol. 2017;13(9):509\u201320.","journal-title":"Nat Rev Endocrinol"},{"key":"933_CR12","first-page":"914938","volume":"3","author":"L Jean-Marc","year":"2012","unstructured":"Jean-Marc L, Abdolnaser P. NAFLD, estrogens, and physical exercise: the animal model. J Nutr Metab. 2012;3:914938.","journal-title":"J Nutr Metab"},{"issue":"3","key":"933_CR13","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3892\/ijmm.2015.2076","volume":"35","author":"C Sun","year":"2015","unstructured":"Sun C, Huang F, Liu X, et al. miR-21 regulates triglyceride and cholesterol metabolism in non-alcoholic fatty liver disease by targeting HMGCR. Int J Mol Med. 2015;35(3):847\u201353.","journal-title":"Int J Mol Med"},{"issue":"3","key":"933_CR14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/MEG.0000000000000254","volume":"27","author":"J Luo","year":"2015","unstructured":"Luo J, Xu L, Li J, et al. Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease. Eur J Gastroenterol Hepatol. 2015;27(3):193.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"933_CR15","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/00000441-200512000-00011","volume":"330","author":"BA Neuschwander Tetri","year":"2005","unstructured":"Neuschwander Tetri BA. Nonalcoholic steatohepatitis and the metabolic syndrome. Am J Med Sci. 2005;330(6):326\u201335.","journal-title":"Am J Med Sci"},{"issue":"5","key":"933_CR16","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.dld.2017.01.147","volume":"49","author":"A Lonardo","year":"2017","unstructured":"Lonardo A, Nascimbeni F, Targher G, et al. AISF position paper on nonalcoholic fatty liver disease (NAFLD): updates and future directions. Dig Liver Dis. 2017;49(5):471\u201383.","journal-title":"Dig Liver Dis"},{"issue":"36","key":"933_CR17","doi-asserted-by":"publisher","first-page":"6571","DOI":"10.3748\/wjg.v23.i36.6571","volume":"23","author":"A Lonardo","year":"2017","unstructured":"Lonardo A, Nascimbeni F, Maurantonio M, et al. Nonalcoholic fatty liver disease: evolving paradigms. World J Gastroenterol. 2017;23(36):6571\u201392.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"933_CR18","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","volume":"67","author":"M Romero-G\u00f3mez","year":"2017","unstructured":"Romero-G\u00f3mez M, Zelber-Sagi S, Trenell M. Treatment of NAFLD with diet, physical activity and exercise. J Hepatol. 2017;67(4):829\u201346.","journal-title":"J Hepatol"},{"issue":"Supplementum 3","key":"933_CR19","doi-asserted-by":"crossref","first-page":"S343","DOI":"10.33549\/physiolres.933439","volume":"65","author":"M Kvandov\u00e1","year":"2016","unstructured":"Kvandov\u00e1 M, Majz\u00fanov\u00e1 M, Dovinov\u00e1 I. The role of PPARgamma in cardiovascular diseases. Physiol Res. 2016;65(Supplementum 3):S343\u201363.","journal-title":"Physiol Res"},{"key":"933_CR20","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.pharmthera.2017.05.011","volume":"179","author":"N Tanaka","year":"2017","unstructured":"Tanaka N, Aoyama T, Kimura S, et al. Targeting nuclear receptors for the treatment of fatty liver disease. Pharmacol Ther. 2017;179:142\u201357.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"933_CR21","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s12325-016-0306-9","volume":"33","author":"S Ballestri","year":"2016","unstructured":"Ballestri S, Nascimbeni F, Romagnoli D, et al. The role of nuclear receptors in the pathophysiology, natural course, and drug treatment of NAFLD in humans. Adv Ther. 2016;33(3):291\u2013319.","journal-title":"Adv Ther"},{"issue":"5","key":"933_CR22","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/0092-8674(95)90193-0","volume":"83","author":"J Chen","year":"1995","unstructured":"Chen J. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell. 1995;83(5):803.","journal-title":"Cell"},{"issue":"22","key":"933_CR23","doi-asserted-by":"publisher","first-page":"12953","DOI":"10.1074\/jbc.270.22.12953","volume":"270","author":"JM Lehmann","year":"1995","unstructured":"Lehmann JM, Moore LB, Smith-Oliver TA, et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem. 1995;270(22):12953\u20136.","journal-title":"J Biol Chem"},{"issue":"73","key":"933_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.plefa.2005.04.008","volume":"73","author":"A Hammarstedt","year":"2005","unstructured":"Hammarstedt A, Andersson CX, Rotter SV, et al. The effect of PPARgamma ligands on the adipose tissue in insulin resistance. Prostaglandins Leukot Essent Fatty Acids. 2005;73(73):65\u201375.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"3","key":"933_CR25","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.yjmcc.2006.06.004","volume":"41","author":"C Pellieux","year":"2006","unstructured":"Pellieux C, Aasum E, Larsen TS, et al. Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway. J Mol Cell Cardiol. 2006;41(3):459\u201366.","journal-title":"J Mol Cell Cardiol"},{"issue":"4","key":"933_CR26","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/hep.1840380427","volume":"38","author":"BA Neuschwandertetri","year":"2003","unstructured":"Neuschwandertetri BA, Brunt EM, Wehmeier KR, et al. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone. Hepatology. 2003;38(4):1008\u201317.","journal-title":"Hepatology"},{"key":"933_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/7403230","volume":"2016","author":"T Mello","year":"2016","unstructured":"Mello T, Materozzi M, Galli A. PPARs and mitochondrial metabolism: from NAFLD to HCC. PPAR Res. 2016;2016:1\u201318.","journal-title":"PPAR Res"},{"issue":"2\u20133","key":"933_CR28","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ejphar.2011.03.033","volume":"659","author":"H Zheng","year":"2011","unstructured":"Zheng H, Li S, Liang M, et al. A novel agonist of PPAR-\u03b3 based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing insulin resistance. Eur J Pharmacol. 2011;659(2\u20133):244\u201351.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"933_CR29","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ejheart.2007.11.005","volume":"10","author":"D Fliegner","year":"2008","unstructured":"Fliegner D, Westermann D, Riad A, et al. Up-regulation of PPARgamma in myocardial infarction. Eur J Heart Fail. 2008;10(1):30.","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"933_CR30","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1161\/01.RES.0000060700.55247.7C","volume":"92","author":"AJ Gilde","year":"2003","unstructured":"Gilde AJ, van der Lee KAJM, Willemsen PHM, et al. Peroxisome proliferator-activated receptor (PPAR) \u03b1 and PPAR\u03b2\/\u03b4, but not PPAR\u03b3, modulate the expression of genes involved in cardiac lipid metabolism. Circ Res. 2003;92(5):518.","journal-title":"Circ Res"},{"issue":"23","key":"933_CR31","doi-asserted-by":"publisher","first-page":"11012","DOI":"10.1073\/pnas.91.23.11012","volume":"91","author":"T Gulick","year":"1994","unstructured":"Gulick T, Cresci S, Caira T, et al. The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc Natl Acad Sci. 1994;91(23):11012.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"933_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11010-005-2997-0","volume":"268","author":"M Tous","year":"2005","unstructured":"Tous M, Ferr\u00e9 N, Camps J, et al. Feeding apolipoprotein E-knockout mice with cholesterol and fat enriched diets may be a model of non-alcoholic steatohepatitis. Mol Cell Biochem. 2005;268(1):53\u20138.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"933_CR33","doi-asserted-by":"publisher","first-page":"12931","DOI":"10.1038\/srep12931","volume":"5","author":"R Schierwagen","year":"2015","unstructured":"Schierwagen R, Mayb\u00fcchen L, Zimmer S, et al. Seven weeks of Western diet in apolipoprotein-E-deficient mice induce metabolic syndrome and non-alcoholic steatohepatitis with liver fibrosis. Sci Rep. 2015;5(1):12931.","journal-title":"Sci Rep"},{"issue":"2","key":"933_CR34","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.nut.2003.10.008","volume":"20","author":"D Estadella","year":"2004","unstructured":"Estadella D, Oyama LM, D\u00e2maso AR, et al. Effect of palatable hyperlipidic diet on lipid metabolism of sedentary and exercised rats. Nutrition. 2004;20(2):218\u201324.","journal-title":"Nutrition"},{"issue":"7","key":"933_CR35","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.fct.2006.01.004","volume":"44","author":"RC Burneiko","year":"2006","unstructured":"Burneiko RC, Diniz YS, Galhardi CM, et al. Interaction of hypercaloric diet and physical exercise on lipid profile, oxidative stress and antioxidant defenses. Food Chem Toxicol. 2006;44(7):1167\u201372.","journal-title":"Food Chem Toxicol"},{"issue":"6","key":"933_CR36","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1152\/japplphysiol.01164.2002","volume":"94","author":"M Gauthier","year":"2003","unstructured":"Gauthier M, Couturier K, Latour J, et al. Concurrent exercise prevents high-fat-diet-induced macrovesicular hepatic steatosis. J Appl Physiol. 2003;94(6):2127\u201334.","journal-title":"J Appl Physiol"},{"issue":"1","key":"933_CR37","first-page":"19","volume":"27","author":"M Straczkowski","year":"2001","unstructured":"Straczkowski M, Kowalska I, Dzienis-Straczkowska S, et al. The effect of exercise training on glucose tolerance and skeletal muscle triacylglycerol content in rats fed with a high-fat diet. Diabetes Metab. 2001;27(1):19\u201323.","journal-title":"Diabetes Metab"},{"issue":"3","key":"933_CR38","doi-asserted-by":"publisher","first-page":"E300","DOI":"10.1152\/ajpendo.00427.2013","volume":"306","author":"MA Linden","year":"2014","unstructured":"Linden MA, Fletcher JA, Morris EM, et al. Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats. Am J Physiol Endocrinol Metab. 2014;306(3):E300.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"7","key":"933_CR39","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3390\/ijms17071002","volume":"17","author":"JA Dom\u00ednguez-Avila","year":"2016","unstructured":"Dom\u00ednguez-Avila JA, Gonz\u00e1lez-Aguilar GA, Alvarez-Parrilla E, et al. Modulation of PPAR expression and activity in response to polyphenolic compounds in high fat diets. Int J Mol Sci. 2016;17(7):1002.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"933_CR40","doi-asserted-by":"publisher","first-page":"b151637","DOI":"10.2337\/db15-1637","volume":"65","author":"X Chen","year":"2016","unstructured":"Chen X, Zhang F, Gong Q, et al. Hepatic ATF6 increases fatty acid oxidation to attenuate hepatic steatosis in mice through peroxisome proliferator-activated receptor alpha. Diabetes. 2016;65(7):b151637.","journal-title":"Diabetes"},{"issue":"9","key":"933_CR41","first-page":"1","volume":"2017","author":"H Han","year":"2017","unstructured":"Han H, Qiu F, Zhao H, et al. Dietary flaxseed oil prevents Western-type diet-induced nonalcoholic fatty liver disease in apolipoprotein-E knockout mice. Oxid Med Cell Longev. 2017;2017(9):1\u201313.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"933_CR42","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.bbrc.2005.08.070","volume":"336","author":"M Inoue","year":"2005","unstructured":"Inoue M, Ohtake T, Motomura W, et al. Increased expression of PPAR\u03b3 in high fat diet-induced liver steatosis in mice. Biochem Biophys Res Commun. 2005;336(1):215\u201322.","journal-title":"Biochem Biophys Res Commun"},{"issue":"49","key":"933_CR43","doi-asserted-by":"publisher","first-page":"37603","DOI":"10.1074\/jbc.M604709200","volume":"281","author":"YL Zhang","year":"2006","unstructured":"Zhang YL, Hernandez-Ono A, Siri P, et al. Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis. J Biol Chem. 2006;281(49):37603\u201315.","journal-title":"J Biol Chem"},{"issue":"1","key":"933_CR44","doi-asserted-by":"publisher","first-page":"19288","DOI":"10.1038\/srep19288","volume":"6","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Gu M, Cai W, et al. Dietary component isorhamnetin is a PPAR\u03b3 antagonist and ameliorates metabolic disorders induced by diet or leptin deficiency. Sci Rep. 2016;6(1):19288.","journal-title":"Sci Rep"},{"issue":"8","key":"933_CR45","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.4254\/wjh.v7.i8.1012","volume":"7","author":"V Souza-Mello","year":"2015","unstructured":"Souza-Mello V. Peroxisome proliferator-activated receptors as targets to treat non-alcoholic fatty liver disease. World J Hepatol. 2015;7(8):1012.","journal-title":"World J Hepatol"},{"issue":"6","key":"933_CR46","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1042\/CS20100061","volume":"119","author":"V Souzamello","year":"2010","unstructured":"Souzamello V, Greg\u00f3rio BM, Cardosodelemos FS, et al. Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL\/6 mice fed on a very high-fat diet. Clin Sci. 2010;119(6):239\u201350.","journal-title":"Clin Sci"},{"issue":"1","key":"933_CR47","first-page":"587140","volume":"2013","author":"T Hirata","year":"2013","unstructured":"Hirata T, Tomita K, Kawai T, et al. Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY). Int J Endocrinol. 2013;2013(1):587140.","journal-title":"Int J Endocrinol"},{"issue":"3","key":"933_CR48","doi-asserted-by":"publisher","first-page":"E531","DOI":"10.1152\/ajpendo.00299.2002","volume":"284","author":"JM Ye","year":"2003","unstructured":"Ye JM, Iglesias MA, Watson DG, et al. PPARalpha \/gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly. Am J Physiol Endocrinol Metab. 2003;284(3):E531.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"933_CR49","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1590\/S0100-879X2010007500030","volume":"43","author":"CMM Marques","year":"2010","unstructured":"Marques CMM, Motta VF, Torres TS, et al. Beneficial effects of exercise training (treadmill) on insulin resistance and nonalcoholic fatty liver disease in high-fat fed C57BL\/6 mice. Braz J Med Biol Res. 2010;43(5):467\u201375.","journal-title":"Braz J Med Biol Res"},{"issue":"6","key":"933_CR50","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s12325-017-0556-1","volume":"34","author":"S Ballestri","year":"2017","unstructured":"Ballestri S, Nascimbeni F, Baldelli E, et al. NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk. Adv Ther. 2017;34(6):1291\u2013326.","journal-title":"Adv Ther"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0933-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-018-0933-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0933-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T19:52:02Z","timestamp":1605988322000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-018-0933-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,5]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["933"],"URL":"https:\/\/doi.org\/10.1186\/s12944-018-0933-z","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,5]]},"assertion":[{"value":"31 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol of animal experiments was complied with the Guide for the Care and Use of Laboratory Animals formulated by the US National Institutes of Health (NIH Publication No. 85\u201323, Revised 1996) and approved by the Animal Care and Ethics Committee of Central South University, Changsha, China.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"6"}}